Literature DB >> 15568022

Protection of p27(Kip1) mRNA by quaking RNA binding proteins promotes oligodendrocyte differentiation.

Daniel Larocque1, André Galarneau, Hsueh-Ning Liu, Michelle Scott, Guillermina Almazan, Stéphane Richard.   

Abstract

The quaking (Qk) locus expresses a family of RNA binding proteins, and the expression of several alternatively spliced isoforms coincides with the development of oligodendrocytes and the onset of myelination. Quaking viable (Qk(v)) mice harboring an autosomal recessive mutation in this locus have uncompacted myelin in the central nervous system owing to the inability of oligodendrocytes to properly mature. Here we show that the expression of two QKI isoforms, absent from oligodendrocytes of Qk(v) mice, induces cell cycle arrest of primary rat oligodendrocyte progenitor cells and differentiation into oligodendrocytes. Injection of retroviruses expressing QKI into the telencephalon of mouse embryos induced differentiation and migration of multipotential neural progenitor cells into mature oligodendrocytes localized in the corpus callosum. The mRNA encoding the cyclin-dependent kinase (CDK)-inhibitor p27(Kip1) was bound and stabilized by QKI, leading to an increased accumulation of p27(Kip1) protein in oligodendrocytes. Our findings demonstrate that QKI is upstream of p27(Kip1) during oligodendrocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15568022     DOI: 10.1038/nn1359

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  84 in total

1.  Type II arginine methyltransferase PRMT5 regulates gene expression of inhibitors of differentiation/DNA binding Id2 and Id4 during glial cell differentiation.

Authors:  Jinghan Huang; Gillian Vogel; Zhenbao Yu; Guillermina Almazan; Stéphane Richard
Journal:  J Biol Chem       Date:  2011-10-31       Impact factor: 5.157

Review 2.  Comparing peripheral glial cell differentiation in Drosophila and vertebrates.

Authors:  Floriano Rodrigues; Imke Schmidt; Christian Klämbt
Journal:  Cell Mol Life Sci       Date:  2010-09-04       Impact factor: 9.261

Review 3.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 4.  Insights into the structural basis of RNA recognition by STAR domain proteins.

Authors:  Sean P Ryder; Francesca Massi
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 5.  Post-translational modifications of nucleosomal histones in oligodendrocyte lineage cells in development and disease.

Authors:  Siming Shen; Patrizia Casaccia-Bonnefil
Journal:  J Mol Neurosci       Date:  2008-05       Impact factor: 3.444

6.  MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer cells via Wnt/β-catenin signaling by repressing the expression of Quaking proteins.

Authors:  Zhejia Zhang; Xinying Li; Qian Xiao; Zhiming Wang
Journal:  Oncol Lett       Date:  2018-02-15       Impact factor: 2.967

7.  An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.

Authors:  Jiaxuan Liu; Ping Wang; Ping Zhang; Xinyu Zhang; Hang Du; Qiang Liu; Bo Huang; Caiyun Qian; Shuhua Zhang; Weifeng Zhu; Xiaohong Yang; Yingqun Xiao; Zhuoqi Liu; Daya Luo
Journal:  J Appl Genet       Date:  2019-08-01       Impact factor: 3.240

8.  Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development.

Authors:  Jenne Relucio; Iva D Tzvetanova; Wei Ao; Sabine Lindquist; Holly Colognato
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

9.  The QKI-6 RNA binding protein regulates actin-interacting protein-1 mRNA stability during oligodendrocyte differentiation.

Authors:  Evgueni Doukhanine; Christina Gavino; Jeffery D Haines; Guillermina Almazan; Stéphane Richard
Journal:  Mol Biol Cell       Date:  2010-07-14       Impact factor: 4.138

10.  The QKI-6 and QKI-7 RNA binding proteins block proliferation and promote Schwann cell myelination.

Authors:  Daniel Larocque; Gabriela Fragoso; Jinghan Huang; Walter E Mushynski; Martin Loignon; Stéphane Richard; Guillermina Almazan
Journal:  PLoS One       Date:  2009-06-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.